PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
Berkley E. Gryder(University School), Javed Khan(Kent State University), Sivasish Sindiri(National Institutes of Health), Xinyu Wen(National Institutes of Health), Craig J. Thomas(National Institutes of Health), Marielle E. Yohe(National Cancer Center), Alberto Gualtieri(Bambino Gesù Children's Hospital), Silvia Pomella(University of Rome Tor Vergata), Frederic G. Barr(National Institutes of Health), Madhu Lal‐Nag(National Center for Advancing Translational Sciences), Jun S. Wei(Center for Cancer Research), Þorkell Andrésson(National Institutes of Health), Rossella Rota(Bambino Gesù Children's Hospital), Keji Zhao(National Heart Lung and Blood Institute), Beat Schaefer(University Hospital Zurich), Nirmalya Sen(National Institutes of Health), Marco Wachtel(University Children's Hospital Zurich), Rajarshi Guha(Vertex Pharmaceuticals (United States)), Hsien-Chao Chou(National Cancer Institute), Abigail H. Cleveland(National Institutes of Health), Joana G. Marques(University Children's Hospital Zurich), Young Song(University of British Columbia), Xiaohu Zhang(Soochow University), Marc Ferrer(National Institute of Biomedical Innovation, Health and Nutrition), Sudipto Das(National Cancer Institute), Jack F. Shern(National Institutes of Health)
Cited by 336
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k